Arcus Biosciences RCUS
NYSE RCUS
$29.65 -0.48 (-1.59%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcus Biosciences (RCUS) Current Taxes (2021 - 2022)

Arcus Biosciences (RCUS) posted quarterly Current Taxes of $18000.0 for Q3 2022, little changed quarter-over-quarter from $18000.0 in Q2 2022.

Analysis

Arcus Biosciences (RCUS) Current Taxes (2021 - 2022) Analysis & Trends

Arcus Biosciences' Current Taxes history runs 2 years deep, the most recent figure standing at $18000.0 for Q3 2022.

  • In Q3 2022, Current Taxes changed N/A year-over-year to $18000.0; the TTM figure through Sep 2022 stood at $18000.0 (changed N/A YoY), while the FY2021 annual figure was $2.0 million, changed N/A from the prior year.
  • Current Taxes for Q3 2022 stood at $18000.0, roughly flat from $18000.0 in the prior quarter.
  • The five-year high for Current Taxes was $2.8 million in Q1 2022, with the low at $18000.0 in Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 49.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 76.32 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Arcus Biosciences 3.74 Bn 3.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 18,000.00
Jun 30, 2022 18,000.00
Mar 31, 2022 2.82 Mn
Dec 31, 2021 2.00 Mn